Brian Haddigan: Beyond Stent Design – The Importance of Blood Compatibility
Brian Haddigan, Chief Executive Officer and Co Founder at Smart Reactors, shared a post on LinkedIn:
“What if the next breakthrough in venous stents isn’t the design, but the surface?
FDA post-market surveillance continues to receive reports of thrombosis, occlusion and restenosis associated with venous stents.
While these reports don’t measure complication rates, they reinforce that blood compatibility remains an important challenge.
Smart Reactors we’ve developed Camouflage, an ultra-thin, non-pharmacological hemocompatible coating designed to create a more blood-friendly surface, reducing platelet and fibrin adhesion while supporting natural healing.
The future of vascular implants includes solid engineering and smarter surfaces.
Could your next-generation device benefit from Camouflage?
Lets connect and find out..”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 22:28Recent Mechanical Risk Factors and Young-Onset Cryptogenic Ischemic Stroke – American Heart Association International
-
Sep 30, 2026, 22:22Expert Consensus on Inferior Vena Cava Thrombosis – Thrombosis and Haemostasis Journal
-
Sep 30, 2026, 22:21Markus Abeln: How Platelets and Complement Shape Placental Blood Flow
-
Sep 30, 2026, 22:19Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
-
Sep 30, 2026, 22:17Sudhir Kumar: Stroke is a Medical Emergency – and Every Minute Matters
-
Sep 30, 2026, 22:15Luisa Medeiros Visentini: Our Research on Cognitive Impairment After CVT Cited in the International Journal of Stroke
-
Sep 30, 2026, 21:50Jagat Narula: Connecting Cardiovascular Health and Sickle Cell Disease on World Heart Day 2026
-
Sep 30, 2026, 21:38John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
-
Sep 30, 2026, 21:36Mark Murphy: Irish Heart Foundation Meets With Senator Teresa Costello on World Heart Day